Wesley Daniel Mallinger, DO - Medicare Pathology in Spartanburg, SC

Wesley Daniel Mallinger, DO is a medicare enrolled "Pathology - Anatomic Pathology & Clinical Pathology" physician in Spartanburg, South Carolina. He went to Edward Via Col Of Osteo Medicine-carolinas Campus and graduated in 2015 and has 9 years of diverse experience with area of expertise as Pathology. He is a member of the group practice Duke Health Integrated Practice Inc and his current practice location is 101 E Wood St, Spartanburg, South Carolina. You can reach out to his office (for appointments etc.) via phone at (407) 595-2181.

Wesley Daniel Mallinger is licensed to practice in North Carolina (license number 2021-00216) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1225411556.

Contact Information

Wesley Daniel Mallinger, DO
101 E Wood St,
Spartanburg, SC 29303-3040
(407) 595-2181
Not Available



Physician's Profile

Full NameWesley Daniel Mallinger
GenderMale
SpecialityPathology
Experience9 Years
Location101 E Wood St, Spartanburg, South Carolina
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Wesley Daniel Mallinger attended and graduated from Edward Via Col Of Osteo Medicine-carolinas Campus in 2015
  NPI Data:
  • NPI Number: 1225411556
  • Provider Enumeration Date: 07/06/2015
  • Last Update Date: 05/28/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 0840507026
  • Enrollment ID: I20210603002881

Medical Identifiers

Medical identifiers for Wesley Daniel Mallinger such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1225411556NPI-NPPES
LL37661OtherSCSC LICENSE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ZP0102XPathology - Anatomic Pathology & Clinical Pathology 2021-00216 (North Carolina)Primary
208600000XSurgery LL37661 (South Carolina)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Duke Health Raleigh HospitalRaleigh, NCHospital
Duke University HospitalDurham, NCHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Duke Health Integrated Practice Inc83254127372551

News Archive

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

According to the American Cancer Society, more than 700,000 new cases of liver cancer are diagnosed worldwide each year.

Majority of Canadians want to keep their commitment to reduce child deaths around the world

GTA parents and children gathered at an African-style clinic in downtown Toronto today, where World Vision released a poll that showed most Canadians (84%) think it's great that a lot of focus is placed on immunizing Canadian children against the H1N1 flu and other diseases. They (79%) want to see just as much focus on immunizing children in poor countries.

LDR submits two-level Mobi-C cervical artificial disc PMA to the FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Blood pressure at the high end of normal still a risk for heart disease

If you're male, and your systolic blood pressure is a little bit on the high side, even though it is still within the normal range, you could be at an increased risk of having heart attack compared to men whose systolic blood pressure is on the low end of normal, Heart and Stroke Foundation researchers say.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Wesley Daniel Mallinger allows following entities to bill medicare on his behalf.
Entity NamePrivate Diagnostic Clinic Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457389033
PECOS PAC ID: 1355254368
Enrollment ID: O20031204000577

News Archive

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

According to the American Cancer Society, more than 700,000 new cases of liver cancer are diagnosed worldwide each year.

Majority of Canadians want to keep their commitment to reduce child deaths around the world

GTA parents and children gathered at an African-style clinic in downtown Toronto today, where World Vision released a poll that showed most Canadians (84%) think it's great that a lot of focus is placed on immunizing Canadian children against the H1N1 flu and other diseases. They (79%) want to see just as much focus on immunizing children in poor countries.

LDR submits two-level Mobi-C cervical artificial disc PMA to the FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Blood pressure at the high end of normal still a risk for heart disease

If you're male, and your systolic blood pressure is a little bit on the high side, even though it is still within the normal range, you could be at an increased risk of having heart attack compared to men whose systolic blood pressure is on the low end of normal, Heart and Stroke Foundation researchers say.

Read more Medical News

› Verified 8 days ago

Entity NameDuke Health Integrated Practice Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1205553369
PECOS PAC ID: 8325412737
Enrollment ID: O20230327002247

News Archive

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

According to the American Cancer Society, more than 700,000 new cases of liver cancer are diagnosed worldwide each year.

Majority of Canadians want to keep their commitment to reduce child deaths around the world

GTA parents and children gathered at an African-style clinic in downtown Toronto today, where World Vision released a poll that showed most Canadians (84%) think it's great that a lot of focus is placed on immunizing Canadian children against the H1N1 flu and other diseases. They (79%) want to see just as much focus on immunizing children in poor countries.

LDR submits two-level Mobi-C cervical artificial disc PMA to the FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Blood pressure at the high end of normal still a risk for heart disease

If you're male, and your systolic blood pressure is a little bit on the high side, even though it is still within the normal range, you could be at an increased risk of having heart attack compared to men whose systolic blood pressure is on the low end of normal, Heart and Stroke Foundation researchers say.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Wesley Daniel Mallinger is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Wesley Daniel Mallinger, DO
5213 S Alston Ave,
Durham, NC 27713-4430

Ph: (919) 620-4855
Wesley Daniel Mallinger, DO
101 E Wood St,
Spartanburg, SC 29303-3040

Ph: (407) 595-2181

News Archive

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

According to the American Cancer Society, more than 700,000 new cases of liver cancer are diagnosed worldwide each year.

Majority of Canadians want to keep their commitment to reduce child deaths around the world

GTA parents and children gathered at an African-style clinic in downtown Toronto today, where World Vision released a poll that showed most Canadians (84%) think it's great that a lot of focus is placed on immunizing Canadian children against the H1N1 flu and other diseases. They (79%) want to see just as much focus on immunizing children in poor countries.

LDR submits two-level Mobi-C cervical artificial disc PMA to the FDA

LDR, a privately held medical device company offering innovative spinal implants for both non-fusion and fusion applications, announced the March 11 submission of its two-level Mobi-C cervical artificial disc PMA to the FDA. LDR is one of only two companies to have completed a two-level randomized IDE trial with two-year follow up, and is the first to submit its results.

Evidence shows bevacizumab therapy improves survival in patients with glioblastoma

A new population-based study has found that patients with glioblastoma who died in 2010, after the Food and Drug Administration (FDA) approval of bevacizumab, had lived significantly longer than patients who died of the disease in 2008, prior to the conditional approval of the drug for the treatment of the deadly brain cancer. Bevacizumab is used to treat patients with certain cancers whose cancer has spread. The study appears in the journal Cancer.

Blood pressure at the high end of normal still a risk for heart disease

If you're male, and your systolic blood pressure is a little bit on the high side, even though it is still within the normal range, you could be at an increased risk of having heart attack compared to men whose systolic blood pressure is on the low end of normal, Heart and Stroke Foundation researchers say.

Read more News

› Verified 8 days ago


Pathology Doctors in Spartanburg, SC

Dr. John Aikman Caldwell, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 101 E Wood St, Spartanburg, SC 29303
Phone: 864-560-6229    
Jeremy J Parris, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 101 E Wood St, Spartanburg, SC 29303
Phone: 704-973-5515    Fax: 704-973-5518
Dr. Rosanna L Lapham, MD
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 101 E Wood St, Spartanburg, SC 29303
Phone: 704-973-5500    
Claudia M. Croitoru, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 106 Venture Blvd, Spartanburg, SC 29306
Phone: 864-583-3850    Fax: 864-583-1405
Dr. William Brownlee Lowry, MD
Pathology
Medicare: Not Enrolled in Medicare
Practice Location: 106 Venture Blvd, Spartanburg, SC 29306
Phone: 864-560-6217    Fax: 864-560-6335
Alexander Spyros Maris, M.D.
Pathology
Medicare: Accepting Medicare Assignments
Practice Location: 101 E Wood St, Spartanburg, SC 29303
Phone: 225-663-9556    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.